STOCK TITAN

Issuer (NASDAQ: SLDB) holder plans 5,704-share Form 144 stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of SLDB common stock filed a notice of proposed sale on Form 144 covering 5,704 shares. These shares were acquired on 01/09/2026 through the settlement of vested restricted stock units from the issuer as compensation. The planned sale is indicated through E*TRADE Financial Corporation, with an approximate aggregate market value of 30,060.08 and an expected sale date of 01/13/2026 on the NASDAQ. The issuer reports 79,162,201 common shares outstanding, providing context for the relative size of this planned transaction.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the SLDB Form 144 filing disclose?

The Form 144 filing for SLDB discloses a planned sale of 5,704 shares of common stock by a holder, with the transaction to take place through E*TRADE Financial Corporation on the NASDAQ.

How many SLDB shares are planned to be sold and at what market value?

The notice covers the planned sale of 5,704 SLDB common shares with an indicated aggregate market value of 30,060.08.

How and when were the SLDB shares in this Form 144 acquired?

The 5,704 SLDB shares were acquired on 01/09/2026 via settlement of vested restricted stock units from the issuer, described as compensation.

On which exchange is the SLDB stock in this filing expected to be sold?

The filing indicates that the SLDB common stock is expected to be sold on the NASDAQ securities exchange.

How many SLDB common shares are outstanding according to this Form 144?

The Form 144 states that there are 79,162,201 SLDB common shares outstanding, which helps put the planned sale of 5,704 shares into context.

Which broker is named in the SLDB Form 144 filing?

The broker named for the planned sale is E*TRADE Financial Corporation, located at 3 Edison Drive, Alpharetta, GA 30005.

Solid Bioscience

NASDAQ:SLDB

SLDB Rankings

SLDB Latest News

SLDB Latest SEC Filings

SLDB Stock Data

440.97M
65.59M
0.52%
105.94%
12.65%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
CHARLESTOWN